Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
-
2021
-
2022
Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF-
Published 2025Subjects: -
2023
DataSheet_1_Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines...
Published 2021“…Purpose<p>Sentinel-lymph-node (SLN) biopsy (SLB) is an efficient and safe axillary surgical approach with decreased morbidity than total axillary lymph node dissection (ALND) in initial patients (T1–T2). …”
-
2024
DataSheet_1_Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines...
Published 2021“…Purpose<p>Sentinel-lymph-node (SLN) biopsy (SLB) is an efficient and safe axillary surgical approach with decreased morbidity than total axillary lymph node dissection (ALND) in initial patients (T1–T2). …”
-
2025
-
2026
-
2027
-
2028
-
2029
-
2030
-
2031
CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex.
Published 2013“…<p>(A) The distribution of rs7120118 genotypes in subgroups divided by the severity of the disease (mild n = 19/18/9; moderate n = 4/4/5; severe n = 10/12/2, rs7120118 genotypes TT/CT/CC, respectively). …”
-
2032
-
2033
-
2034
-
2035
C9C5 immunoreactivity in the mouse hypothalamus across life.
Published 2020“…<p>(A-F) Immunostaining with the C9C5 antibody on coronal sections of the hypothalamus at P4 (A) (n = 3), P10 (B) (n = 3), P20 (C) (n = 4), and at two (D) (n = 4), nine (E) (n = 3) and twelve (F) (n = 4) months. …”
-
2036
-
2037
-
2038
-
2039
-
2040